Education
About Us
Working with TipRanks
Follow Us
DocMorris AG (CH:DOCM)
:DOCM
Earnings Data
Report Date
Mar 19, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
―Last Year’s EPS
-2.47Same Quarter Last Year
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in key areas such as the Rx business and TeleClinic, supported by a successful capital increase and strategic innovations like the DocMorris Health Companion. However, challenges such as a decline in adjusted EBITDA and the impact of the Zur Rose pharmacy closure were also noted. The overall impression is of a company on a positive trajectory, despite some financial setbacks.Company Guidance
Rx Business Revenue Growth
The Rx business delivered strong growth with revenues increasing by 43.5% in the first half of 2025.
TeleClinic Revenue Surge
TeleClinic revenues grew by more than 150% year-on-year, contributing significantly to the company's gross profit.
Capital Increase Success
A CHF 200 million capital increase was successfully completed with a 99% take-up rate, reflecting strong shareholder support.
Launch of DocMorris Health Companion
The rollout of the DocMorris Health Companion leveraging AI innovation marks a strategic step forward in becoming a digital health platform.
Non-Rx Business Growth
The non-Rx business showed steady and profitable growth with revenues up 4.4% year-on-year.
Retail Media Business Expansion
The retail media business is scaling rapidly, with expected mid-single-digit million EBITDA contribution this year.
Gross Margin Improvement
Gross margin improved by 70 basis points year-on-year, driven by better pricing and increased contribution of high-margin service businesses.
CH:DOCM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CH:DOCM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 19, 2025 | CHF7.66 | CHF6.78 | -11.49% |
Mar 13, 2025 | CHF10.40 | CHF7.42 | -28.65% |
Aug 20, 2024 | CHF23.53 | CHF20.60 | -12.45% |
Mar 21, 2024 | CHF39.29 | CHF39.20 | -0.23% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does DocMorris AG (CH:DOCM) report earnings?
DocMorris AG (CH:DOCM) is schdueled to report earning on Mar 19, 2026, TBA (Confirmed).
What is DocMorris AG (CH:DOCM) earnings time?
DocMorris AG (CH:DOCM) earnings time is at Mar 19, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of DocMorris AG stock?
The P/E ratio of DocMorris is N/A.
What is CH:DOCM EPS forecast?
Currently, no data Available